Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive studyGuillaume Manson, Jean‐Marie Michot|Journal for ImmunoTherapy of Cancer|2019Cited by 105